Received 27 August 1999/Returned for modification 20 December
1999/Accepted 10 March 2000
Glycopeptide-resistant enterococci of the VanC type synthesize
UDP-muramyl-pentapeptide[D-Ser] for cell wall assembly
and prevent synthesis of peptidoglycan precursors ending in
D-Ala. The vanC cluster of Enterococcus
gallinarum BM4174 consists of five genes: vanC-1,
vanXYC, vanT,
vanRC, and vanSC. Three
genes are sufficient for resistance: vanC-1
encodes a ligase that synthesizes the dipeptide
D-Ala-D-Ser for addition to
UDP-MurNAc-tripeptide, vanXYC encodes
a D,D-dipeptidase-carboxypeptidase that
hydrolyzes D-Ala-D-Ala and removes
D-Ala from UDP-MurNAc-pentapeptide[D-Ala], and vanT encodes a membrane-bound serine racemase that
provides D-Ser for the synthetic pathway. The three genes
are clustered: the start codons of vanXYC and
vanT overlap the termination codons of vanC-1
and vanXYC, respectively. Two genes which
encode proteins with homology to the VanS-VanR two-component
regulatory system were present downstream from the resistance
genes. The predicted amino acid sequence of
VanRC exhibited 50% identity to VanR and 33% identity to
VanRB. VanSC had 40% identity to VanS
over a region of 308 amino acids and 24% identity to VanSB
over a region of 285 amino acids. All residues with important functions
in response regulators and histidine kinases were conserved in
VanRC and VanSC, respectively. Induction
experiments based on the determination of
D,D-carboxypeptidase activity in
cytoplasmic extracts confirmed that the genes were expressed
constitutively. Using a promoter-probing vector, regions upstream
from the resistance and regulatory genes were identified that have
promoter activity.
 |
INTRODUCTION |
High-level resistance to
glycopeptides in enterococci results from the synthesis of
peptidoglycan precursors ending in D-lactate (D-Lac) (VanA, VanB, and VanD types) (4, 31) and
the elimination of high-affinity D-alanine
(D-Ala)-ending precursors synthesized by the host (5,
33). Low-level resistance to vancomycin is found in strains
belonging to the VanC and VanE types which incorporate D-Ser into the C-terminal position of UDP-muramyl
pentapeptide (9, 17, 34). In strains with VanA, VanB, or
VanD phenotypes, synthesis of D-Ala-D-Lac
requires the presence of a ligase of altered specificity
(11) and a dehydrogenase that reduces pyruvate to
D-Lac (6). In VanC-type strains, ligase genes
(vanC-1, vanC-2, and vanC-3) (15,
26) that encode proteins necessary for the synthesis of
D-Ala-D-Ser have been characterized
(29). Synthesis of D-Ser is carried out by a
pyridoxal phosphate-dependent and membrane-bound serine racemase (VanT)
(2).
Hydrolysis of precursors (ending in D-Ala) synthesized by
the host prevents the interaction of the glycopeptide molecule with its
target (35). Two enzymes are involved in performing this function: VanX (VanXB) is a
D,D-dipeptidase that hydrolyzes
D-Ala-D-Ala (33) and VanY
(VanYB) is a
D,D-carboxypeptidase that hydrolyzes the
terminal D-Ala residue of late peptidoglycan precursors
that are synthesized if elimination of
D-Ala-D-Ala by the host is not complete
(5). In Enterococcus gallinarum BM4174,
representative of the VanC type of resistance, both activities are
encoded by the same gene, vanXYC
(36). VanXYC contains consensus sequences for
binding zinc, stabilizing the binding of substrate and catalyzing hydrolysis that are present in both VanX- and VanY-type enzymes. The
protein has very low dipeptidase activity against
D-Ala-D-Ser (unlike VanX) and no activity
against UDP-MurNAc-pentapeptide[D-Ser] (36).
A two-component regulatory system controls the expression of resistance
genes in VanA- and VanB-type strains (2, 14). The system
comprises genes that encode response regulators (VanR and
VanRB) and histidine kinase proteins (VanS and
VanSB) (7, 40). The C-terminal kinase domain of
VanS undergoes autophosphorylation on a histidine residue in the
presence of ATP and transfers the phosphate group to VanR
(40). Phospho-VanR (P-VanR and P-VanRB) activate
transcription of the resistance genes and of their own genes after
binding to promoter regions upstream from the resistance (PvanH) and regulatory
(PvanR) genes (20). A similar gene
cluster has been described in VanD-type strains (13). We
describe here the gene cluster responsible for vancomycin resistance in
E. gallinarum BM4174. The cluster comprised five genes:
three were necessary and sufficient for resistance (vanC-1,
vanXYC, and vanT) and the remaining
two (vanRC and vanSC)
encoded a two-component regulatory system.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and growth conditions.
Bacterial strains and plasmids used in this work are described in Table
1 and Fig.
1. Enterococci were grown in
brain-heart-yeast extract (BHY) (Difco Laboratories, Detroit, Mich.)
broth or on BHY agar. Gentamicin (Sigma, Steinheim, Germany), 150 µg/ml, was added to the medium for Enterococcus faecalis
JH2-2 containing derivatives of plasmid pAT392 (5), and
spectinomycin (Duchefa, Haarlem, The Netherlands), 480 µg/ml, was
added for E. gallinarum BM4174 containing plasmid
derivatives of pAT78 (3). Vancomycin (4 µg/ml) was added
to the medium to test for induction of
D,D-dipeptidase activity in E. gallinarum BM4174. Escherichia coli XL1-Blue
(12) was grown in Luria-Bertani (Difco) broth or agar
containing 100 µg of ampicillin per ml when derivatives of pUC18
(27) were present, gentamicin (8 µg/ml) when containing
derivatives of pAT392 (5), or spectinomycin (60 µg/ml)
when containing derivatives of pAT78 (3). Restriction
profiles of pAT392 and pAT78 derivatives from enterococci and from
E. coli were compared to screen for any DNA rearrangement.
MICs of vancomycin and chloramphenicol for E. faecalis JH2-2
and E. gallinarum BM4174 were determined by using twofold
dilutions of the antibiotic in BHY broth with an inoculum of
106 cells per ml and after 48 h of incubation at
37°C.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
Physical map of the vanC gene cluster. The
fragments cloned in plasmids pCA10, pCA11, and pCA12 are indicated by
thin solid lines. Thick arrows represent coding sequences and indicate
the direction of transcription. The fragment cloned into pCA11 contains
the intergenic region between orf1 and vanC-1
including the 3' end of orf1 and the 5' end of
vanC-1. The insert of plasmid pCA12 contains the intergenic
region between vanT and vanRC
(including the 3' end of vanT and the 5' end of
vanRC). Cloning of the inserts of pCA8 and pCA9
was performed by inverse PCR using oligonucleotides A, B, C, and D
(represented by small arrows) containing SacI and
XbaI sites at the 5' and 3' ends, respectively, after
digestion and self-religation of total DNA from E. gallinarum BM4174 with HindIII and PvuI
(asterisks). Numbers above each gene indicate the percentage of GC.
Restriction sites: P, PvuI; S, SacI; Sl,
SalI; H, HindIII; X, XbaI.
|
|
DNA manipulations.
E. gallinarum BM4174 total DNA was
extracted as described earlier (32). Cloning, digestion with
restriction endonucleases (Boehringer-Mannheim, Mannheim, Germany),
isolation of plasmid DNA (Wizard Plus SV Minipreps; Promega), ligation,
and transformation were carried out by standard methods
(38). Plasmid constructs based on pAT392 (5) and
pAT78 (3) were purified from E. coli and
electroporated into E. faecalis JH2-2 and E. gallinarum BM4174, respectively, as described elsewhere
(14).
Cloning and sequencing of the vanRC and
vanSC genes.
The sequences of the
vanRC gene and the 5' end of the
vanSC gene were obtained from plasmid pCA1
(2). The remaining portion of the
vanSC gene was obtained by inverse PCR
(28) after digestion of chromosomal DNA with
HindIII. A digoxigenin (Boehringer-Mannheim)-labeled probe from the 5' end of the vanSC gene
hybridized (41) to a 3.6-kb HindIII fragment
of chromosomal DNA. Total DNA was then digested with
HindIII and self-ligated at 16°C for 16 h at a
concentration of 10 µg/ml. The inverse PCR with Pwo
polymerase (Boehringer-Mannheim) was performed with primers A and B
(Table 2 and Fig. 1). The PCR product
obtained had the expected size of 2.5 kb based on the size of the
HindIII fragment and the oligonucleotides used as
primers. This product was used in the construction of pCA8.
Cloning of DNA upstream from the vanC-1 gene.
Cloning of DNA upstream from the vanC-1 gene (15)
was performed by inverse PCR (28). In brief, a
digoxigenin-labeled probe from the 5' end of vanC-1
hybridized (41) to a 1.8-kb PvuI fragment. Chromosomal DNA was digested with PvuI and self-ligated as
described above. PCR with Pwo polymerase was performed with
primers C and D (Table 2 and Fig. 1). The PCR product obtained was of
the expected size of 1.4 kb. The fragment was used in the construction
of pCA9.
Plasmid construction.
Plasmid pCA1 has been described
(2). For construction of plasmids pCA8 and pCA9, the 2.5- and 1.4-kb SacI-XbaI inverse PCR products were
purified with a commercial kit (QIAquick Gel Purification Kit; Qiagen),
digested with SacI and XbaI, and ligated with
pUC18 DNA digested with the same enzymes: the insert in plasmid pCA8
contained DNA downstream from the extreme 5' end of
vanSC, and the region upstream from
vanC-1 was present in plasmid pCA9 (Table 1). Plasmid pCA10
was constructed by cloning a PCR product containing the
vanC-1, vanXYC, and vanT
genes obtained after amplification of E. gallinarum BM4174
chromosomal DNA with primers E and F (Table 2). The product was
digested with SacI and XbaI, purified, and cloned, under the control of the P2 promoter to
allow constitutive expression of the gene products, into pAT392
(5) digested with the same enzymes. For construction of
plasmid pCA11, DNA containing the orf1-vanC-1 intergenic
region and the 3' and 5' ends of orf1 and vanC-1,
respectively (Fig. 1), was amplified (using Pwo polymerase) with primers G and H (Table 2) using the total DNA of E. gallinarum BM4174 as a template. The 703-bp fragment,
corresponding to nucleotides 655 to 1357 (see Fig. 3), was digested
with BamHI and SalI and ligated to pAT78 DNA
(3) digested with the same enzymes. Similarly, a DNA
fragment from E. gallinarum BM4174 containing the
vanT-vanRC intergenic region and the 3' and 5'
ends of vanT and vanRC, respectively (Fig. 1), was amplified using primers I and J (Table 2). The 473-bp PCR
fragment was digested with BamHI and SalI,
purified, and ligated with pAT78 DNA (3) digested with the
same enzymes to obtain plasmid pCA12. The cloning was designed to
position both fragments upstream from the promoterless chloramphenicol acetyltransferase (CAT) gene cat in pAT78 (3).
DNA sequence and accession numbers.
Sequencing of the
inserts in pCA8 and pCA9 (two independent clones of each) was performed
by the dideoxy chain terminator method (39) using
fluorescent cycle sequencing with dye-labeled terminators (ABI Prism TM
Dye Terminator Cycle Sequencing Ready Reaction Kit; Perkin-Elmer) on a
373A automated DNA sequencer (Perkin-Elmer). The nucleotide sequences
have been deposited in GenBank (accession number AF162694).
Extraction and analysis of peptidoglycan precursors from E. faecalis JH2-2/pCA10 (vanC-1 vanXYC
vanT).
Extraction and analysis of peptidoglycan precursors
were performed as described elsewhere (34). In brief,
enterococci were grown in BHY medium supplemented with
D-Ser or L-Ser or in the absence of any
supplement. Ramoplanin was added to inhibit peptidoglycan synthesis and
incubation continued for 15 min to cause accumulation of peptidoglycan
precursors. Bacteria were harvested, and cytoplasmic precursors were
extracted and analyzed by high-performance liquid chromatography (HPLC).
D,D-Dipeptidase and CAT activities.
D,D-Dipeptidase activity was measured in
cytoplasmic extracts of E. gallinarum BM4174 grown in the
presence or absence of vancomycin (4 µg/ml). The amount of
D-Ala released from D-Ala-D-Ala was determined using a D-amino acid oxidase assay coupled
to peroxidase (24). For CAT activity, E. gallinarum BM4174 and the same strain containing pAT78, pCA11, or
pCA12 were grown to an optical density of 0.8 at 600 nm in BHY medium
supplemented with spectinomycin (480 µg/ml) to prevent the loss of
pAT78 and derivatives. The cells were lysed with lysozyme and M1
muramidase as described earlier (2). Cytoplasmic extracts
obtained after centrifugation at 40,000 × g for 20 min
were tested for the formation of 5-thio-2-nitrobenzoate at 37°C in
the presence or absence of chloramphenicol in 5 mM phosphate buffer (pH
7.2) (3). Protein concentrations were determined according
to the method of Bradford (10) with bovine serum albumin as
a standard.
 |
RESULTS AND DISCUSSION |
Nucleotide sequences of the vanRC and
vanSC genes.
The sequences of the
vanRC and vanSC genes
(Fig. 2) were obtained by sequencing on
both strands the inserts of plasmids pCA1 (2) and pCA8.
vanR extended from nucleotides 143 to 838. The proposed
initiation codon was preceded by a sequence
(5'-TAGGTGGAGT N8 ATG) with
similarity to ribosome binding sites (RBS) of gram-positive bacteria
(25) and displayed limited complementarity
(underlined) to the 3'-OH terminus of Bacillus subtilis 16S
rRNA (3'-OH UCUUUCCUCC). The sequence encoded a putative protein of 231 amino acids (Mr, 26,523) designated VanRC. There was no obvious translation
start site in the second open reading frame (ORF) downstream from
vanRC. The amino acid sequence deduced from the
ORF starting at the first putative in-frame initiation codon (TTG at
position 828, Fig. 2) would correspond to a protein of 361 amino acids
(Mr, 41,462) that was
designated VanSC. Other in-frame putative initiation codons
(TTG at positions 846 and 861) were also not preceded by obvious RBS.
The organization of vanRC-vanSC is
similar to that described for vanR-vanS in VanA-type
strains, including the overlap of the two genes, the TTG start codon
and no obvious RBS preceding the start of the vanS gene
(3). Moreover, although the genes encoding the putative
regulatory proteins were found downstream from the resistance genes it
is likely that they are involved in the regulation of the vancomycin
resistance gene cluster: other genes encoding proteins which could be
involved in vancomycin resistance were not found downstream from
vanRC-vanSC; instead, a gene
encoding a putative D-Ala-D-Ala ligase was
found downstream from vanSC but in opposite
orientation to the five genes of the vanC cluster (C. A. Arias and P. E. Reynolds, Abstr. 38th Intersci. Conf.
Antimicrob. Agents Chemother., abstr. C-84, 1998).

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 2.
Sequence of the vanRC and
vanSC genes. The deduced amino acid sequences
are shown below the nucleotide sequence. The deduced amino acid
sequence of the C terminus of VanT is shown above the nucleotide
sequence. Clusters of hydrophobic amino acids in VanSC
predicted to represent transmembrane regions (21) are shown
in boldface. The putative RBS of vanRC is
indicated in italics.
|
|
Amino acid sequence comparisons of VanRC and
VanSC.
The highest score of a BLAST (1)
search of the OWL protein sequence database was obtained with VanR from
E. faecium BM4147 (3): VanRC had the
same number of amino acid residues (231 residues) as VanR and displayed
50% identity (3). The protein with the next highest degree
of identity was the GtcR putative response regulator from
Bacillus brevis (43) (41% identity over 229 amino acids). VanRC exhibited only 33% identity with
VanRB (16). The conserved lysine and aspartate
residues typical of response regulators (42) of
two-component regulatory systems were also present in VanRC
(Lys102, Asp10, and Asp53) (Fig. 3). The
high degree of identity between VanRC and VanR suggests an evolutionary relatedness. VanSC had 40% identity with VanS
over a region of 308 amino acids (highest BLAST score) and 24% with VanSB over a region of 285 amino acids. The highest degree
of identity between VanSC, VanS, and VanSB was
found in the C-terminal region. VanSC contained the five
conserved motifs characteristic of transmitter modules of histidine
protein kinases (Fig. 4) (19). A hydrophobicity plot (23) of the N-terminal domain of
VanSC indicated two clusters of hydrophobic amino acids
that may correspond to transmembrane regions (Fig. 2), as in the sensor
domains of VanS and VanSB (7). The structural
homology of VanRC and VanSC with proteins of
the two-component regulatory systems in VanA-type strains further
supports the fact that a similar signal-transducing system controlling
the expression of proteins involved in vancomycin resistance is likely
to be present in E. gallinarum BM4174.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 3.
Alignment of the deduced amino acid sequence of VanRc
from E. gallinarum BM4174, VanR from E. faecium
BM4147 (3), and VanRb from E. faecalis V583
(16). The alignment was made by using CLUSTAL W
(18). Numbers at the left correspond to the position of the
first amino acid in the corresponding line. Black boxes indicate amino
acid identity, and shaded boxes indicate similar amino acids. Asp10,
Asp53, and Lys102 in VanRC, which are conserved in the
effector domain of other response regulators (42), are
indicated above the alignment. Asp53 of VanR is phosphorylated by the
associated histidine kinase VanS (40).
|
|

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 4.
Alignment of the deduced amino acid sequence of VanSc
from E. gallinarum BM4174, VanS from E. faecium
BM4147 (3), and VanSb from E. faecalis V583
(16). The alignment was made using CLUSTAL W
(18). Numbers at the left correspond to the position of the
first amino acid in the corresponding line. Black boxes indicate the
amino acid identity, and shaded boxes indicate similar amino acids.
Conserved sequence motifs H, N, G1, F, and G2 (29) are
indicated above the alignment. His147 in VanSC corresponds
to the putative autophosphorylation site.
|
|
Nucleotide sequence upstream from vanC-1.
The sequence
upstream from vanC-1 revealed an ORF with a proposed
initiation codon preceded by a putative RBS. The 810-bp sequence from
position 94 to 903 (Fig. 5) encoded a
putative 269-amino-acid protein
(Mr, 29,718) that was
designated ORF1. The intergenic region between orf1 and the
start of vanC-1 contained 348 bp (Fig. 5). ORF1 had homology
(32 to 35% identity over 215 to 226 amino acids) to ATP-binding
transporter proteins (ABC transporters) from different organisms (PotG
from Rickettsia prowazekii, NrtC from Oscillatoriacean
cyanobacterium, and PotA from Haemophilus influenzae).
This type of protein has not previously been associated with
glycopeptide resistance and was not necessary for vancomycin resistance in E. gallinarum BM4174 (see below):
therefore, ORF1 is unlikely to be part of the vanC
gene cluster.

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 5.
Sequence of orf1 upstream from the
vanC-1 gene. The deduced amino acid sequence is shown below
the nucleotide sequence. The deduced amino acid sequence of the N
terminus of VanC-1 is shown above the nucleotide sequence. The putative
RBS of orf1 is underlined. The hexanucleotides exhibiting
similarity to the 35 (TTGATC) and 10
(TAGACT) consensus promoter sequences (from
PvanH of vancomycin-resistant E. faecium) (20) (underlined above) are shown in
boldface.
|
|
Constitutive synthesis of D,D-dipeptidase
in E. gallinarum BM4174.
The presence of genes
encoding a two-component regulatory system, adjacent to the resistance
genes, prompted us to study the influence of vancomycin on the
expression of the resistance genes. D,D-Dipeptidase activity, used as a reporter,
was not increased after growth in the presence of vancomycin,
indicating that the antibiotic did not have an upregulating effect on
expression of the resistance genes (Table
3) and that vancomycin resistance was
expressed constitutively in BM4174. However, strains of E. gallinarum that exhibit inducible expression of resistance have also been described (37). We have characterized 15 strains
of vancomycin-resistant E. gallinarum which express the
resistance phenotype either constitutively (seven strains) or inducibly
(eight strains); using PCR we were able to identify and sequence the vanRC-vanSC genes in all isolates.
Additionally, in all strains, the genes were detected downstream from
vanT as in E. gallinarum BM4174 (C. A. Arias, D. Panesso, and P. E. Reynolds, unpublished data). These
findings indicate that the vanRC and
vanSC genes are most likely to play a role in
the regulation of the resistance genes. Mutations in the H box of the
histidine kinase domain of VanSB have been shown to convert
an inducible to a constitutive glycopeptide resistance phenotype
(5, 6, 44). Alignment of the predicted amino acid sequence
in the H box of VanSC with VanSB (Fig. 4)
indicated that these mutations were not present in VanSC.
In vivo characterization of VanSB in E. coli has
shown that VanSB functioned only as a phosphatase with no
kinase activity (38). If VanSC in E. gallinarum BM4174 were to function in a similar way as VanS or
VanSB a constitutive phenotype could result from a protein
that had kinase but no phosphatase activity or was lacking both
activities. A functional analysis of the
VanRC-VanSC two-component regulatory system in
E. gallinarum is currently in progress to clarify this
issue.
trans-activation of transcription of cat.
Plasmids pCA11 and pCA12 (Fig. 1) contained, respectively, the
orf1-vanC-1 intergenic region (including the 3' end of
orf1 and the 5' end of vanC-1) and the
vanT-vanRC intergenic region (including the 3'
end of vanT and the 5' end of vanRC)
cloned upstream from the promoterless cat gene of pAT78
(3). Both plasmids increased the MIC of
chloramphenicol against E. gallinarum BM4174 eightfold, and
the CAT activity was increased ca. 50-fold relative to the strain
harboring pAT78 only (Table 3). These data indicated that DNA regions
upstream from both the vanC-1 and
vanRC genes could function as promoters and
allowed trans-activation of cat transcription.
Genes necessary for vancomycin resistance in E. gallinarum BM4174.
Plasmid pCA10 was obtained by cloning
into pAT392 a fragment containing the vanC-1,
vanXYC, and vanT genes to allow
constitutive expression of the genes under the control of the
P2 promoter (5). Electroporation of
pCA10 DNA into E. faecalis JH2-2 led to a
fourfold increase in the vancomycin MIC (Table 3). Analysis of
peptidoglycan precursors indicated production of
UDP-MurNAc-pentapeptide[Ser] (23% of total precursor pool),
reflecting both VanC-1 and VanT activities and of UDP-MurNAc
tetrapeptide (74% of the total precursor pool) resulting from
hydrolysis of UDP-MurNAc-pentapeptide[Ala] by the
D,D-carboxypeptidase activity of
VanXYC (Table 4). Presence of
either L-Ser or D-Ser in the growth medium
slightly increased the percentage of UDP-MurNAc-pentapeptide[Ser]
synthesized by the host (40 and 38%, respectively), although it had no
effect on the level of resistance to vancomycin (Table 4). The stop codons of vanC-1 and vanXYC overlap
the initiation codons of vanXYC and
vanT, respectively (2, 36), suggesting that
translational coupling may play a role in expression of the resistance
proteins. The data also confirm that the metabolic pathway for the
synthesis of UDP-MurNAc-pentapeptide[Ser] in E. gallinarum
BM4174 involves racemization of L-serine by VanT (a
membrane-bound serine racemase) (2), followed by synthesis
of D-Ala-D-Ser (29) which is added to
UDP-MurNAc-L-Ala-
-D-Glu-L-Lys.
In order to eliminate "susceptible" precursors (ending in
D-Ala), hydrolysis of D-Ala-D-Ala
(D,D-dipeptidase activity) and removal of
D-Ala from UDP-MurNAc-pentapeptide
(D,D-carboxypeptidase activity) occurs
(36). These two functions are catalyzed by a single protein
(VanXYC) (36), unlike the VanA and VanB
phenotypes in which two polypeptides (VanX/VanY or
VanXB/VanYB) are necessary (5,
33). Peptidoglycan precursor analysis (Table 4) indicates that
both activities are required for the successful removal of "susceptible" precursors: a considerable proportion of
accumulated tetrapeptide suggests that elimination of
D-Ala-D-Ala is not complete.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Peptidoglycan precursors and vancomycin MICs for E. faecalis JH2-2 and derivatives under different growth conditions
|
|
In summary, the vanC gene cluster is considered to comprise
five genes, vanC-1, vanXYC,
vanT, vanRC, and
vanSC. The gene organization differs from that
in the vanA, vanB, and vanD gene
clusters (12; Arias and Reynolds, 38th ICAAC) in
that the vanRC-vanSC genes are
positioned downstream from the resistance genes. The presence of
VanC-1, VanXYC, and VanT is necessary and sufficient
for resistance.
C.A.A. is funded by COLCIENCIAS (Instituto Colombiano para el
Desarrollo de la Ciencia y Tecnología, "Francisco José
de Caldas") and the Overseas Research Scheme Award from the Committee of Vice-Chancellors and Principals of Universities in the United Kingdom. Part of this work was carried out while C.A.A. was the recipient of a British Infection Society/Hoechst-Marion-Roussel Travel
Bursary held at the Institut Pasteur, Paris, France. This work was
supported in part by the Programme de Recherche Fondamentale en
Microbiologie, Maladies infectieuses et parasitaires from the Ministère de l'Education Nationale de la Recherche et de la
Technologie. We are grateful to the Cambridge Overseas Trust and T. Blundell, Department of Biochemistry, University of Cambridge, for
personal financial assistance to C.A.A.
We thank M. Arthur for helpful discussions and J. Lester and C. Hill,
Cambridge Center for Molecular Recognition, for DNA sequencing and
synthesis of oligonucleotides, respectively.
| 1.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 2.
|
Arias, C. A.,
M. Martín-Martinez,
T. L. Blundell,
M. Arthur,
P. Courvalin, and P. E. Reynolds.
1999.
Characterization and modelling of VanT, a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174.
Mol. Microbiol.
31:1653-1664[CrossRef][Medline].
|
| 3.
|
Arthur, M.,
C. Molinas, and P. Courvalin.
1992.
The VanS-VanR two- component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.
J. Bacteriol.
174:2582-2591[Abstract/Free Full Text].
|
| 4.
|
Arthur, M.,
P. E. Reynolds, and P. Courvalin.
1996.
Glycopeptide resistance in enterococci.
Trends Microbiol.
4:401-407[CrossRef][Medline].
|
| 5.
|
Arthur, M.,
F. Depardieu,
H. A. Snaith,
P. E. Reynolds, and P. Courvalin.
1994.
Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors.
Antimicrob. Agents Chemother.
38:1899-1903[Abstract/Free Full Text].
|
| 6.
|
Arthur, M.,
C. Molinas,
S. Dutka-Malen, and P. Courvalin.
1991.
Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases.
Gene
103:133-134[CrossRef][Medline].
|
| 7.
|
Baptista, M.,
F. Depardieu,
P. E. Reynolds,
P. Courvalin, and M. Arthur.
1997.
Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci.
Mol. Microbiol.
25:93-105[CrossRef][Medline].
|
| 8.
|
Baptista, M.,
P. Rodrigues,
F. Depardieu,
P. Courvalin, and M. Arthur.
1999.
Single-cell analysis of glycopeptide resistance gene expression in teicoplanin-resistant mutants of a VanB-type Enterococcus faecalis.
Mol. Microbiol.
32:17-28[CrossRef][Medline].
|
| 9.
|
Billot-Klein, D.,
L. Gutmann,
S. Sable,
E. Guitet, and J. van Heijenoort.
1994.
Association constants for the binding of vancomycin and teicoplanin to N-acetyl-D-alanyl-D-alanine and N-acetyl-D-alanyl-D-serine.
Biochem. J.
304:1021-1022.
|
| 10.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 11.
|
Bugg, T. D. H.,
G. D. Wright,
S. Dutka-Malen,
M. Arthur,
P. Courvalin, and C. T. Walsh.
1991.
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.
Biochemistry
30:10408-10415[CrossRef][Medline].
|
| 12.
|
Bullock, W. O.,
J. M. Fernandez, and J. M. Short.
1987.
XL1-Blue a high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection.
BioTechniques
5:376.
|
| 13.
|
Casadewall, B., and P. Courvalin.
1999.
Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339.
J. Bacteriol.
181:3644-3648[Abstract/Free Full Text].
|
| 14.
|
Cruz-Rodz, A. L., and M. S. Gilmore.
1990.
High efficiency introduction of plasmid DNA into glycine-treated Enterococcus faecalis by electroporation.
Mol. Gen. Genet.
224:152-154[CrossRef][Medline].
|
| 15.
|
Dutka-Malen, S.,
C. Molinas,
M. Arthur, and P. Courvalin.
1992.
Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance.
Gene
112:53-58[CrossRef][Medline].
|
| 16.
|
Evers, S., and P. Courvalin.
1996.
Regulation of VanB-type vancomycin resistance gene expression by the VanSB-VanRB two-component regulatory system in Enterococcus faecalis V583.
J. Bacteriol.
178:1302-1309[Abstract/Free Full Text].
|
| 17.
|
Fines, M.,
B. Perichon,
P. Reynolds,
D. F. Sahm, and P. Courvalin.
1999.
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405.
Antimicrob. Agents Chemother.
43:2161-2164[Abstract/Free Full Text].
|
| 18.
|
Higgins, D. G.,
J. D. Thompson, and T. J. Gibson.
1996.
Using CLUSTAL for multiple sequence alignments.
Methods Enzymol.
266:383-402[Medline].
|
| 19.
|
Hoch, J. A., and T. J. Silhavy.
1995.
Two-component signal transduction.
American Society for Microbiology, Washington, D.C.
|
| 20.
|
Holman, T. R.,
Z. Wu,
B. L. Wanner, and C. T. Walsh.
1994.
Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium.
Biochemistry
33:4625-4631[CrossRef][Medline].
|
| 21.
|
Holmann, K., and W. Stoffel.
1993.
TMBase a database of membrane spanning protein segments.
Biol. Chem. Hoppe-Seyler
374:166.
|
| 22.
|
Jacob, A. E., and S. J. Hobbs.
1974.
Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.
J. Bacteriol.
174:5982-5984[Abstract/Free Full Text].
|
| 23.
|
Kyte, J., and R. F. Doolittle.
1982.
A simple method for displaying hydropathic character of a protein.
J. Mol. Biol.
157:105-132[CrossRef][Medline].
|
| 24.
|
Messer, J., and P. E. Reynolds.
1992.
Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci.
FEMS Microbiol. Lett.
94:195-200[CrossRef].
|
| 25.
|
Moran, C. P.,
N. Lang,
S. F. J. LeGrice,
G. Lee,
M. Stephens,
A. L. Sonenshein,
J. Pero, and R. Losick.
1982.
Nucleotide sequences that signal the initiation of transcription and translation in Bacillus subtilis.
Mol. Gen. Genet.
186:339-346[CrossRef][Medline].
|
| 26.
|
Navarro, F., and P. Courvalin.
1994.
Analysis of genes encoding D-alanine:D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens.
Antimicrob. Agents Chemother.
38:1788-1793[Abstract/Free Full Text].
|
| 27.
|
Norrander, J.,
T. Kempe, and J. Messing.
1983.
Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis.
Gene
26:101-106[CrossRef][Medline].
|
| 28.
|
Ochman, H.,
A. S. Gerber, and D. L. Hart.
1988.
Genetic applications of an inverse polymerase reaction.
Genetics
120:621-623[Abstract/Free Full Text].
|
| 29.
|
Park, I. S.,
L. Chung-Hung, and C. T. Walsh.
1997.
Bacterial resistance to vancomycin: overproduction, purification, and characterization of VanC-2 from Enterococcus casseliflavus as a D-Ala:D-Ser ligase.
Proc. Natl. Acad. Sci. USA
94:10040-10044[Abstract/Free Full Text].
|
| 30.
|
Parkinson, J. S., and E. C. Kofoid.
1992.
Communication modules in bacterial signaling proteins.
Annu. Rev. Genet.
26:71-112[CrossRef][Medline].
|
| 31.
|
Perichon, B.,
P. E. Reynolds, and P. Courvalin.
1997.
VanD-type glycopeptide-resistant Enterococcus faecium BM4339.
Antimicrob. Agents Chemother.
41:2016-2018[Abstract].
|
| 32.
|
Pitcher, D. G.,
N. A. Saunders, and R. J. Owen.
1989.
Rapid extraction of bacterial genomic DNA with guanidinium thiocyanate.
Lett. Appl. Microbiol.
8:151-156.
|
| 33.
|
Reynolds, P. E.,
F. Depardieu,
S. Dutka-Malen,
M. Arthur, and P. Courvalin.
1994.
Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires VanX for hydrolysis of D-alanyl-D-alanine.
Mol. Microbiol.
13:1065-1070[CrossRef][Medline].
|
| 34.
|
Reynolds, P. E.,
H. A. Snaith,
A. J. Maguire,
S. Dutka-Malen, and P. Courvalin.
1994.
Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174.
Biochem. J.
301:5-8.
|
| 35.
|
Reynolds, P. E.
1998.
Control of peptidoglycan synthesis in vancomycin-resistant enterococci: D,D-peptidases and D,D-carboxypeptidases.
Cell. Mol. Life Sci.
54:325-331[CrossRef][Medline].
|
| 36.
|
Reynolds, P. E.,
C. A. Arias, and P. Courvalin.
1999.
Gene vanXYC encodes both D,D-dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174.
Mol. Microbiol.
34:341-349[CrossRef][Medline].
|
| 37.
|
Sahm, D. F.,
L. Free, and S. Handwerger.
1995.
Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum.
Antimicrob. Agents Chemother.
39:1480-1484[Abstract].
|
| 38.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 39.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 40.
|
Silva, J. C.,
A. Haldimann,
M. K. Prahalad,
C. T. Walsh, and B. L. Wanner.
1998.
In vivo characterization of type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in Escherichia coli: a nonpathogenic model for studying the VRE signal transduction pathways.
Proc. Natl. Acad. Sci. USA
95:11951-11956[Abstract/Free Full Text].
|
| 41.
|
Southern, E. M.
1975.
Detection of specific sequences among DNA fragments separated by gel electrophoresis.
J. Mol. Biol.
98:503-517[CrossRef][Medline].
|
| 42.
|
Stock, J. B.,
A. J. Ninfa, and A. M. Stock.
1989.
Protein phosphorylation and regulation of adaptive responses in bacteria.
Microbiol. Rev.
53:450-490[Abstract/Free Full Text].
|
| 43.
|
Turgay, K., and M. A. Marahiel.
1995.
The gtcRS operon coding for two-component system regulatory proteins is located adjacent to the grs operon of Bacillus brevis.
DNA Seq.
5:283-290[Medline].
|
| 44.
|
Van Bambeke, F.,
M. Chauvel,
P. E. Reynolds,
H. Fraimow, and P. Courvalin.
1999.
Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.
Antimicrob. Agents Chemother.
43:41-47[Abstract/Free Full Text].
|